Global MicroRNA Professional Market

Global MicroRNA (miRNA) Professional Market Insights, Players, Region, Type & Application Analysis 2018-2029

Global MicroRNA Professional Market

Global MicroRNA (miRNA) Professional Market Insights, Players, Region, Type & Application Analysis 2018-2029


Get latest Market Research Reports on MicroRNA (miRNA). Industry analysis and Market Report on MicroRNA (miRNA) is a syndicated market report, published as Global MicroRNA (miRNA) Market Research Report . It is complete Research Study and Industry Analysis of MicroRNA (miRNA) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

The global MicroRNA (miRNA) market size in 2022 is 1173.9 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 17.20% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:

The main players in the MicroRNA (miRNA) market include Merck KGaA (Germany), QIAGEN (Germany), Thermo Fisher Scientific Inc. (U.S.), Synlogic (U.S.), and GeneCopoeia, Inc (U.S.). The share of the top 3 players in the MicroRNA (miRNA) market is XX%.

REGION SHARE:

The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of MicroRNA (miRNA) market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:

The report segments the market by Type and Application. Cancer accounted for XX% of MicroRNA (miRNA) market in 2022. Infectious Diseases share of XX%.

Biotechnology accounted for XX% of the MicroRNA (miRNA) market in 2022. Pharmaceutical Companies accounts for XX%.

The cumulative impact of COVID-19, Russia-Ukraine conflict, and high inflation is expected to have a significant long-term impact on the global MicroRNA (miRNA) markets. Ongoing research considers changes in consumer behavior, supply chain disruptions, and government intervention caused by the pandemic. Likewise, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine conflict and its potential impact on the supply-demand balance, pressure on pricing variables, and import, export, and trade. In addition, the report discusses the impact of high inflation on the global economy and details fiscal policies to measure and reduce its impact on demand, supply, cash flows, and currency exchange.

Market Statistics:

Reports provide market sizes and forecasts for multiple major currencies (USD, EUR, JPY, GBP, CNY, etc.); multi-currency support helps organizational leaders make informed decisions. This report takes 2018-2021 as the historical year, 2022 as the base year, 2023 as the semi-forecast year, and 2024-2029 as the full forecast year.

Market Share Analysis:

Market share analysis provides deep insights into the current status of vendors in a particular market space. By comparing suppliers' contributions to total revenue, customer base, and other key metrics, we can give companies a better understanding of their performance and the challenges they face as they compete for market share. The analysis also sheds light on the competitiveness of any given sector in terms of accumulation, diversification of strengths, and consolidation characteristics during the base year studied.

The report provides insights on the following metrics:

Market Penetration: Provides comprehensive information on the market offered by key players

Market Diversification: Provides detailed information on new product launches, greenfield regions, recent developments and investments

Market Trends: A Big Picture of the Cumulative Impact of COVID-19, Russia-Ukraine Conflict, and High Inflation

Competitive assessment and intelligence: Provides an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape and manufacturing capabilities of leading players

Product Development & Innovation: Provides intelligent insights into future technologies, R&D activities, and breakthrough product developments

Market Segmentation: Segment by Type, Application, and Region to provide detailed insights into market information.

The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.

Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.

Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.

Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.

Highlights-Regions

North America

Europe

China

Japan

Korea

Southeast Asia

India

South America

Middle East & Africa

Player list

Merck KGaA (Germany)

QIAGEN (Germany)

Thermo Fisher Scientific Inc. (U.S.)

Synlogic (U.S.)

GeneCopoeia, Inc (U.S.)

Horizon Discovery Ltd. (U.K.)

New England Biolabs (U.S.)

Quantabio (U.S.)

NanoString (U.S.)

BioGenex (U.S.)

SeqMatic LLC (U.S.)

Miltenyi Biotec (Germany)

Agilent Technologies, Inc (U.S.)

Promega Corporation (U.S.)

Abcam plc (U.K.)

KANEKA CORPORATION (Japan)

Types list

Cancer

Infectious Diseases

Immunological Disorder

Cardiovascular Diseases

Neurological Diseases

Other

Application list

Biotechnology

Pharmaceutical Companies

Academic

Government Research Institutes

Others

Table of Content

1 MicroRNA (miRNA) Market Introduction and Overview

1.1 MicroRNA (miRNA) Definition

1.2 Market Size Analysis by Types

1.3 Market Size Analysis by Application

1.4 Research Purposes

1.5 Report Timeline

1.6 Economic Analysis of Global Regions

1.7 Inflation Analysis

1.8 The Impact of the Russian-Ukrainian War on the Market

2 Market Competition by Manufacturers

2.1 Global MicroRNA (miRNA) Revenue and Market Share by Manufacturer

2.2 Manufacturers MicroRNA (miRNA) Production Sites, Area Served, Product Types

2.3 MicroRNA (miRNA) Market Competitive Situation and Trends

2.3.1 MicroRNA (miRNA) Market Concentration Rate

2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2023

2.3.3 Mergers & Acquisitions, Expansion

3 Players Profiles

3.1 Merck KGaA (Germany)

3.1.1 Merck KGaA (Germany) Company Profile

3.1.2 MicroRNA (miRNA) Product Overview

3.1.3 Merck KGaA (Germany) MicroRNA (miRNA) Market Performance (2018-2023)

3.1.4 Merck KGaA (Germany) Business Overview

3.2 QIAGEN (Germany)

3.2.1 QIAGEN (Germany) Company Profile

3.2.2 MicroRNA (miRNA) Product Overview

3.2.3 QIAGEN (Germany) MicroRNA (miRNA) Market Performance (2018-2023)

3.2.4 QIAGEN (Germany) Business Overview

3.3 Thermo Fisher Scientific Inc. (U.S.)

3.3.1 Thermo Fisher Scientific Inc. (U.S.) Company Profile

3.3.2 MicroRNA (miRNA) Product Overview

3.3.3 Thermo Fisher Scientific Inc. (U.S.) MicroRNA (miRNA) Market Performance (2018-2023)

3.3.4 Thermo Fisher Scientific Inc. (U.S.) Business Overview

3.4 Synlogic (U.S.)

3.4.1 Synlogic (U.S.) Company Profile

3.4.2 MicroRNA (miRNA) Product Overview

3.4.3 Synlogic (U.S.) MicroRNA (miRNA) Market Performance (2018-2023)

3.4.4 Synlogic (U.S.) Business Overview

3.5 GeneCopoeia, Inc (U.S.)

3.5.1 GeneCopoeia, Inc (U.S.) Company Profile

3.5.2 MicroRNA (miRNA) Product Overview

3.5.3 GeneCopoeia, Inc (U.S.) MicroRNA (miRNA) Market Performance (2018-2023)

3.5.4 GeneCopoeia, Inc (U.S.) Business Overview

3.6 Horizon Discovery Ltd. (U.K.)

3.6.1 Horizon Discovery Ltd. (U.K.) Company Profile

3.6.2 MicroRNA (miRNA) Product Overview

3.6.3 Horizon Discovery Ltd. (U.K.) MicroRNA (miRNA) Market Performance (2018-2023)

3.6.4 Horizon Discovery Ltd. (U.K.) Business Overview

3.7 New England Biolabs (U.S.)

3.7.1 New England Biolabs (U.S.) Company Profile

3.7.2 MicroRNA (miRNA) Product Overview

3.7.3 New England Biolabs (U.S.) MicroRNA (miRNA) Market Performance (2018-2023)

3.7.4 New England Biolabs (U.S.) Business Overview

3.8 Quantabio (U.S.)

3.8.1 Quantabio (U.S.) Company Profile

3.8.2 MicroRNA (miRNA) Product Overview

3.8.3 Quantabio (U.S.) MicroRNA (miRNA) Market Performance (2018-2023)

3.8.4 Quantabio (U.S.) Business Overview

3.9 NanoString (U.S.)

3.9.1 NanoString (U.S.) Company Profile

3.9.2 MicroRNA (miRNA) Product Overview

3.9.3 NanoString (U.S.) MicroRNA (miRNA) Market Performance (2018-2023)

3.9.4 NanoString (U.S.) Business Overview

3.10 BioGenex (U.S.)

3.10.1 BioGenex (U.S.) Company Profile

3.10.2 MicroRNA (miRNA) Product Overview

3.10.3 BioGenex (U.S.) MicroRNA (miRNA) Market Performance (2018-2023)

3.10.4 BioGenex (U.S.) Business Overview

3.11 SeqMatic LLC (U.S.)

3.11.1 SeqMatic LLC (U.S.) Company Profile

3.11.2 MicroRNA (miRNA) Product Overview

3.11.3 SeqMatic LLC (U.S.) MicroRNA (miRNA) Market Performance (2018-2023)

3.11.4 SeqMatic LLC (U.S.) Business Overview

3.12 Miltenyi Biotec (Germany)

3.12.1 Miltenyi Biotec (Germany) Company Profile

3.12.2 MicroRNA (miRNA) Product Overview

3.12.3 Miltenyi Biotec (Germany) MicroRNA (miRNA) Market Performance (2018-2023)

3.12.4 Miltenyi Biotec (Germany) Business Overview

3.13 Agilent Technologies, Inc (U.S.)

3.13.1 Agilent Technologies, Inc (U.S.) Company Profile

3.13.2 MicroRNA (miRNA) Product Overview

3.13.3 Agilent Technologies, Inc (U.S.) MicroRNA (miRNA) Market Performance (2018-2023)

3.13.4 Agilent Technologies, Inc (U.S.) Business Overview

3.14 Promega Corporation (U.S.)

3.14.1 Promega Corporation (U.S.) Company Profile

3.14.2 MicroRNA (miRNA) Product Overview

3.14.3 Promega Corporation (U.S.) MicroRNA (miRNA) Market Performance (2018-2023)

3.14.4 Promega Corporation (U.S.) Business Overview

3.15 Abcam plc (U.K.)

3.15.1 Abcam plc (U.K.) Company Profile

3.15.2 MicroRNA (miRNA) Product Overview

3.15.3 Abcam plc (U.K.) MicroRNA (miRNA) Market Performance (2018-2023)

3.15.4 Abcam plc (U.K.) Business Overview

3.16 KANEKA CORPORATION (Japan)

3.16.1 KANEKA CORPORATION (Japan) Company Profile

3.16.2 MicroRNA (miRNA) Product Overview

3.16.3 KANEKA CORPORATION (Japan) MicroRNA (miRNA) Market Performance (2018-2023)

3.16.4 KANEKA CORPORATION (Japan) Business Overview

4 Global MicroRNA (miRNA) Historical and Forecast Market Analysis by Type

4.1 Global MicroRNA (miRNA) Revenue and Market Share by Type

4.2 Global MicroRNA (miRNA) Revenue Market Forecast by Type (2023-2029)

5 Global MicroRNA (miRNA) Historical and Forecast Market Analysis by Application

5.1 Global MicroRNA (miRNA) Revenue Market Share by Application (2018-2023)

5.2 MicroRNA (miRNA) Revenue Market Forecast by Application (2023-2029)

6 Global Market Growth Trends Analysis

6.1 Global MicroRNA (miRNA) Market Size & Forecast (2018-2029)

6.2 MicroRNA (miRNA) Growth Trends Analysis by Regions

6.2.1 MicroRNA (miRNA) Market Size by Regions: 2018 VS 2023 VS 2029

6.2.2 MicroRNA (miRNA) Historic Revenue Market Size by Regions (2018-2023)

6.2.3 MicroRNA (miRNA) Forecasted Revenue Market Size by Regions (2023-2029)

6.2.4 North America MicroRNA (miRNA) Market Size & Forecast (2018-2029)

6.2.5 Europe MicroRNA (miRNA) Market Size & Forecast (2018-2029)

6.2.6 China MicroRNA (miRNA) Market Size & Forecast (2018-2029)

6.2.7 Japan MicroRNA (miRNA) Market Size & Forecast (2018-2029)

6.2.8 Korea MicroRNA (miRNA) Market Size & Forecast (2018-2029)

6.2.9 Southeast Asia MicroRNA (miRNA) Market Size & Forecast (2018-2029)

6.2.10 India MicroRNA (miRNA) Market Size & Forecast (2018-2029)

6.2.11 South America MicroRNA (miRNA) Market Size & Forecast (2018-2029)

6.2.12 Middle East & Africa MicroRNA (miRNA) Market Size & Forecast (2018-2029)

7 North America

7.1 North America MicroRNA (miRNA) Revenue by Players

7.2 North America MicroRNA (miRNA) Revenue by Types

7.3 North America MicroRNA (miRNA) Revenue by Applications

7.4 North America MicroRNA (miRNA) Revenue, Gross and Gross Margin (2018-2023)

7.5 North America PEST Analysis

8 Europe

8.1 Europe MicroRNA (miRNA) Revenue by Players

8.2 Europe MicroRNA (miRNA) Revenue by Types

8.3 Europe MicroRNA (miRNA) Revenue by Applications

8.4 Europe MicroRNA (miRNA) Revenue, Gross and Gross Margin (2018-2023)

8.5 Europe PEST Analysis

9 China

9.1 China MicroRNA (miRNA) Revenue by Players

9.2 China MicroRNA (miRNA) Revenue by Types

9.3 China MicroRNA (miRNA) Revenue by Applications

9.4 China MicroRNA (miRNA) Revenue, Gross and Gross Margin (2018-2023)

9.5 China PEST Analysis

10 Japan

10.1 Japan MicroRNA (miRNA) Revenue by Players

10.2 Japan MicroRNA (miRNA) Revenue by Types

10.3 Japan MicroRNA (miRNA) Revenue by Applications

10.4 Japan MicroRNA (miRNA) Revenue, Gross and Gross Margin (2018-2023)

10.5 Japan PEST Analysis

11 Korea

11.1 Korea MicroRNA (miRNA) Revenue by Players

11.2 Korea MicroRNA (miRNA) Revenue by Types

11.3 Korea MicroRNA (miRNA) Revenue by Applications

11.4 Korea MicroRNA (miRNA) Revenue, Gross and Gross Margin (2018-2023)

11.5 Korea PEST Analysis

12 Southeast Asia

12.1 Southeast Asia MicroRNA (miRNA) Revenue by Players

12.2 Southeast Asia MicroRNA (miRNA) Revenue by Types

12.3 Southeast Asia MicroRNA (miRNA) Revenue by Applications

12.4 Southeast Asia MicroRNA (miRNA) Revenue, Gross and Gross Margin (2018-2023)

12.5 Southeast Asia PEST Analysis

13 India

13.1 India MicroRNA (miRNA) Revenue by Players

13.2 India MicroRNA (miRNA) Revenue by Types

13.3 India MicroRNA (miRNA) Revenue by Applications

13.4 India MicroRNA (miRNA) Revenue, Gross and Gross Margin (2018-2023)

13.5 India PEST Analysis

14 South America

14.1 South America MicroRNA (miRNA) Revenue by Players

14.2 South America MicroRNA (miRNA) Revenue by Types

14.3 South America MicroRNA (miRNA) Revenue by Applications

14.4 South America MicroRNA (miRNA) Revenue, Gross and Gross Margin (2018-2023)

14.5 South America PEST Analysis

15 Middle East & Africa

15.1 Middle East & Africa MicroRNA (miRNA) Revenue by Players

15.2 Middle East & Africa MicroRNA (miRNA) Revenue by Types

15.3 Middle East & Africa MicroRNA (miRNA) Revenue by Applications

15.4 Middle East & Africa MicroRNA (miRNA) Revenue, Gross and Gross Margin (2018-2023)

15.5 Middle East & Africa PEST Analysis

16 MicroRNA (miRNA) Business Cost Analysis

16.1 Proportion of Business Cost Structure

16.1.1 Labor Cost

16.1.2 Operating Expenses

16.2 MicroRNA (miRNA) Industrial Chain Analysis

17 MicroRNA (miRNA) Industry Dynamic Analysis

17.1 MicroRNA (miRNA) Market Trends Analysis

17.2 MicroRNA (miRNA) Market Drivers Analysis

17.3 MicroRNA (miRNA) Market Challenges Analysis

17.4 MicroRNA (miRNA) Market Restraints Analysis

18 Research Findings and Conclusion

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
MicroRNA (miRNA) Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
What trends are influencing the growth of the MicroRNA (miRNA) Market?
New players are entering the MicroRNA (miRNA) Market, while established companies are changing their business models and strategies. This pattern is likely to continue for the foreseeable future.
What are the major applications for MicroRNA (miRNA)?
MicroRNA (miRNA) has a wide range of applications, including and others.
What is the estimated size & growth rate of the MicroRNA (miRNA) Market?
In recent years, the MicroRNA (miRNA) Market has grown at an incredible rate. From 2025 to 2030, the market is expected to grow at a CAGR of yy%.
In the current situation, what value does the MicroRNA (miRNA) Market have?
The value of the MicroRNA (miRNA) Market is estimated to be USD XXX million.
What does the future hold for the MicroRNA (miRNA) Industry?
This latest research publication on the MicroRNA (miRNA) Market is an in-depth market tracker that provides a comprehensive assessment of the challenges that manufacturers face in achieving new growth cycles in the current scenario.